OTC: WINT

Windtree Therapeutics, Inc.

Healthcare | Biotechnology

$0.01

Volume70.0K

Windtree Therapeutics, Inc. (OTC: WINT) is a biotechnology company trading at $0.01. Figures from SEC EDGAR and market feeds; updated 2026-10-11 00:41 UTC.

What Windtree Therapeutics, Inc. does

The company is a biotechnology firm developing therapies for critical conditions, with a lead candidate called istaroxime for acute heart failure and cardiogenic shock that has received Fast Track designation from the FDA. Its pipeline includes preclinical SERCA2a activators for heart failure, rostafuroxin for hypertension in patients with specific genetic profiles, and an atypical protein kinase C inhibitor for oncology indications, along with existing licensing partnerships.

Summarized from Windtree Therapeutics, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Quote
Price	$0.01
Volume	70.0K shares
Valuation	8-K 2026-07-22
Return on equity	-36.67%

Price Chart

Interactive chart available in terminalPrice charts with full OHLCV data, volume overlay, and technical indicators.
Open WINT in Platform →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity

Source: SEC EDGAR · Filed 2024-10-09

No insider filings in the last 24 months. Most recent filed transactions — October 2024:

2024-10-09President and CEOPurchase5,431$4.9K
2024-07-24SVP, Chief Medical OfficerAward2,674—
2024-07-24President and CEOAward19—

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2025-Q2

JANE STREET GROUP, LLC14,599$7.5KNEW
Tower Research Capital LLC (TRC)2,212$1.1K+60.8%
BANK OF AMERICA CORP /DE/103$53+3.0%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2026-01-07Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2025-08-04Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2025-06-27Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →

Company news

View all →

No qualifying company news in the archive. Full tape in the platform →

Questions this page answers

What does Windtree Therapeutics, Inc. do?

What is WINT's valuation?

WINT trades at $0.01, as of 2026-10-11.

When did WINT last file with the SEC?

Windtree Therapeutics, Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-22. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-10-11 00:41 UTC. This page is also available as JSON at /api/data?ticker=WINT and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for WINT and 5,000+ tickers.

Create a free account — keep WINT

For your agent

GET /api/data?ticker=WINT

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt